Recent Comments

University neurologists launch multiple sclerosis research study (40)
Joy wrote: Hey Ginger, Not only have I not been "scanned… [More]
University neurologists launch multiple sclerosis research study (40)
Joy wrote: Good Luck and God bless. I am certain that a detai… [More]
University neurologists launch multiple sclerosis research study (40)
Larry Edwards wrote: The USA has to get with the program and help peopl… [More]
University neurologists launch multiple sclerosis research study (40)
Ginger MacQueen wrote: Hey Joy! I too am disgusted with Canadian MS Socie… [More]
AMPYRA for MS: Acorda Therapeutics announces wholesale pricing and patient assistance program (6)
nelson perez wrote: Please, I have MS for 8 years, slowly my ability t… [More]
Sunbeds Bill to prevent under-18s from using tanning salons receives high-profile support (1)
Tracie wrote: I think it's sad that we are so bent out of shape … [More]

<< NOAA awards $457,000 grant to track and manage outbreaks of toxic red tide algae | First edition: October 5, 2009 >>

NanoViricides completes a number of financing activities

5. October 2009 07:35

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that it has completed a number of financing activities.

The Company has successfully raised more than $4.3M. This raise involved issuance of restricted shares and warrant conversions in private placements to certain accredited investors. The Company is filing a Form 8-K disclosure with the SEC summarizing these activities on October 5, 2009.

“With sufficient working capital to last us through December 31, 2010,” said Eugene Seymour, MD, MPH, CEO of the Company, “we are now ready to engage full steam with our high priority drug development activities.”

http://www.nanoviricides.com/

611cbcf1-978a-4967-8388-2a2241652e74|0|.0

Posted in: Business / Finance

Tags: Bird Flu, H1N1, H5N1, Hepatitis C, Herpes, Influenza, Swine Flu, Virus

VELCADE based regimens are cost-effective for payers and patients, finds studyMillennium: The Takeda Oncology Company today announced that two studies presented at the 51st Ameri...Campaign to end pediatric HIV/AIDS launched in AfricaAt the launch of the Campaign to End Pediatric HIV/AIDS (CEPA) on Thursday, advocate Graca Machel ur...Baxter receives marketing authorization for CELVAPAN H1N1 pandemic influenza vaccineBaxter International Inc. today confirmed that the European Commission (EC) has granted marketing au...Scientists say each person with swine flu will infect two othersScientists in New Zealand who have been examining the spread of the new H1N1 flu (swine flu), say th...Do patients at risk for B-cell malignancy need antiviral treatment?Some studies have shown that a relationship of hepatitis C (HCV) infection with type II mixed cryogl...Age-adjusted death rates in U.S. down sharply in 2006Age-adjusted death rates in the United States dropped significantly between 2005 and 2006 and life e...Worker involved in British bird flu outbreak undergoing tests for the virusAccording to the Health Protection Agency (HPA) in Britain one of the workers who had been dealing w...George Bush needs more money to cope with bird fluU.S. President George Bush is about to reveal his plans to fight a flu pandemic and apparently he wi...

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Add comment

Quirky Comment Title
Name*
E-mail* (Will show your Gravatar icon)
Country Country flag

b i u quote

Comment
Preview

Notify me when new comments are added

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

Free!

Recent Comments

Twitter

Information

NanoViricides completes a number of financing activities

Recent Articles

New Articles

Free!

Recent Comments

Twitter

Information

NanoViricides completes a number of financing activities

Medical News Cloud

Recent Articles

New Articles